Skip to main content
BBNX logo

BBNX · Beta Bionics, Inc. · Proposed Sales

Track BBNX — free
$16.57 -0.02 (-0.12%) At close · Sep 11
Market Cap
$745.48M
Shares
44.99M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-09-09 MARK HOPMAN 40,305
2026-09-03 Mark Hopman 5,327
2026-09-03 Michael R. Mensinger 4,375
2026-09-03 Stephen Feider 6,675
2026-09-03 Sean Saint 16,867
2026-09-03 Steven Jon Russell 4,221
2026-06-24 CHRISTINA JONES 1,406
2026-06-04 CHRISTINA JONES 2,811
2026-06-03 Michael R. Mensinger 4,378
2026-06-03 Steven Jon Russell 4,222
2026-06-03 Stephen Feider 6,676
2026-06-03 Mark Hopman 5,329
2026-06-03 Sean Saint 16,872
2026-05-21 CHRISTINA JONES 1,998
2026-05-21 ADAM LEZACK 1,998
2026-03-04 Mark Hopman 353
2026-03-04 Michael R. Mensinger 1,064
2026-03-04 Sean Saint 3,384
2026-03-04 Stephen Feider 1,428
2026-01-02 MICHAEL MENSINGER 10,000
2026-01-02 Stephen Feider 20,000
2025-12-04 Stephen Feider 1,427
2025-12-04 Michael R. Mensinger 1,063
2025-12-04 Mark Hopman 2,061
2025-12-04 Sean Saint 3,278
2025-10-31 MARIA PALASIS 2,812
2025-10-31 ADAM LEZACK 2,812
2025-10-03 Stephen Feider 4,982
2025-10-01 Stephen Feider 15,018
2025-09-08 Feider Stephen 9,900
2025-09-05 Hopman Mark 11,411
2025-09-05 Feider Stephen 100
2025-09-04 Hopman Mark 6,818
2025-08-22 Feider Stephen 4,413
2025-08-19 Feider Stephen 5,587
2025-08-19 Hopman Mark 16,158
2025-06-09 Sean Saint 3,439
Showing 1–37 of 37 filings
Key facts CIK 1674632 CUSIP 08659B102 13F (30d) 55 filings 55 filers Visit website Investor relations